An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis
Clinical trial NCT03390101 · COMPLETED
Trial details
- NCT number
- NCT03390101
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-26
- Primary completion
- 2018-07-30
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.